Dr. Stephen Hahn Nominated to Head FDA
Hahn is chief medical executive of The University of Texas MD Anderson Cancer Center in Houston
MONDAY, Nov. 4, 2019 (HealthDay News) -- Radiation oncology expert Stephen Hahn, M.D., has been nominated as the new U.S. Food and Drug Administration commissioner.
Hahn, 59, is chief medical executive of The University of Texas MD Anderson Cancer Center in Houston, and he has been a professor of radiation oncology there since January 2015, CNN reported.
Ned Sharpless, M.D., acting commissioner of the FDA, will return to his role as the director of the U.S. National Cancer Institute, the U.S. Department of Health and Human Services said.
The FDA has a $5.7 billion budget and more than 17,000 employees, CNN reported.